Orbimed Advisors LLC Increases Stake in C4 Therapeutics Inc
| CCCC Stock | USD 1.37 0.13 8.67% |
About 62% of C4 Therapeutics' investor base is looking to short. The analysis of the overall investor sentiment regarding C4 Therapeutics suggests that many traders are alarmed. The current market sentiment, together with C4 Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use C4 Therapeutics stock news signals to limit their universe of possible portfolio assets.
Overview of the Recent Transaction On September 30, 2024, Orbimed Advisors LLC, a prominent investment firm, executed a significant transaction by acquiring an
Read at gurufocus.com
 |
C4 Therapeutics Fundamental Analysis
We analyze C4 Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of C4 Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of C4 Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Return On Equity
Return On Equity Comparative Analysis
C4 Therapeutics is currently under evaluation in return on equity category among its peers. Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
C4 Therapeutics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with C4 Therapeutics stock to make a market-neutral strategy. Peer analysis of C4 Therapeutics could also be used in its relative valuation, which is a method of valuing C4 Therapeutics by comparing valuation metrics with similar companies.
Peers
C4 Therapeutics Related Equities
| PRLD | Prelude Therapeutics | 13.64 | ||||
| IPSC | Century Therapeutics | 1.92 | ||||
| MLYS | Mineralys Therapeutics, | 0.53 | ||||
| RVMD | Revolution Medicines | 1.18 | ||||
| NRIX | Nurix Therapeutics | 1.54 | ||||
| EWTX | Edgewise Therapeutics | 2.28 | ||||
| ARVN | Arvinas | 3.53 | ||||
| KYMR | Kymera Therapeutics | 4.46 | ||||
| RZLT | Rezolute | 4.90 | ||||
| FHTX | Foghorn Therapeutics | 5.08 | ||||
| STTK | Shattuck Labs | 5.21 | ||||
| CGEM | Cullinan Oncology | 6.43 | ||||
| GLUE | Monte Rosa | 8.42 |
Complementary Tools for CCCC Stock analysis
When running C4 Therapeutics' price analysis, check to measure C4 Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy C4 Therapeutics is operating at the current time. Most of C4 Therapeutics' value examination focuses on studying past and present price action to predict the probability of C4 Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move C4 Therapeutics' price. Additionally, you may evaluate how the addition of C4 Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |